Le Lézard
Classified in: Health
Subjects: AVO, MAT

Statement of Robin Koval, CEO and President, Truth Initiative® on the House Committee on Oversight and Reform's Subcommittee on Economic and Consumer Policy hearing, 'Examining JUUL's role in the youth e-cigarette epidemic'


WASHINGTON, July 26, 2019 /PRNewswire/ -- Congressional hearings about JUUL's role in the youth e-cigarette epidemic proved, with the company's own testimony and documents, that JUUL has become Big Tobacco 2.0. Committee members shared multiple exhibits that exposed how JUUL's strategies and actions are straight from the tobacco industry's playbook. The startling evidence presented during the questioning of JUUL Co-founder and Chief Product Officer, James Monsees, and Chief Administrative Officer Ashley Gould, indicates that:

Truth Initiative. (PRNewsFoto/Truth Initiative) (PRNewsfoto/Truth Initiative)

Despite JUUL repeatedly claiming that it is not Big Tobacco, the company's actions and testimony tell a very different story. Through repeated misrepresentations, misremembrances and obfuscation, JUUL showed itself to have studied the tone and tactics of the industry they claim to be trying to disrupt and to be taking them to a new level in what we can only characterize as Big Tobacco 2.0. The testimonies provided an abundance of new information and facts that we will share with young people through our truth® campaign to reveal how JUUL is targeting and recruiting a new generation and putting their future health at risk for profit. 

 

SOURCE Truth Initiative


These press releases may also interest you

at 03:00
Young children can largely get away with pulling a tantrum when they are not given what they want. Grown-ups, not so much. Seeing a rebuffed adult making a scene in public is awkward, whether it's about cutting in line, getting VIP treatment, or...

at 02:45
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Enspryngtm (satralizumab-mwge) as the first and only subcutaneous treatment for adults living with...

at 02:05
The Edogawa NICHE Prize for the year 2020 has been awarded to Dr. John Craig Venter for his contribution to research and development pertaining to the Human genome. This honor reflects Dr. Venter's lifetime accomplishments in the power of the...

at 01:29
The food recall warning issued on August 1, 2020 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. The Modern Meat...

14 aoû 2020
OncoSec Medical Incorporated (the "Company" or "OncoSec") today announced that it intends to offer and sell shares of its common stock in a public offering. The offering is subject to market conditions, and there can be no assurance as to whether or...

14 aoû 2020
Swiss biotech company Memo Therapeutics AG (MTx) and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx's therapeutic COVID-19...



News published on 26 july 2019 at 10:24 and distributed by: